Dr. Mobin Paul

Consult Dr. Mobin Paul

Name:

Dr. Mobin Paul

Experience:

10 Years

Hospital

Aster Hospitals

Locations

Kochi

Gender

Male

Languages Spoken

Malayalam ,English, Hindi

Designation

Consultant - Hematology and Hemato Oncology

About Dr. Mobin Paul

Dr. Mobin Paul has nearly 10 years of experience treating malignant and benign hematology. He has completed MBBS from the Government Medical College in Thrissur, an MD in General Medicine from the famed St John’s Medical College Hospital in Bengaluru, and a DM in Clinical Hematology from the world-renowned Christian Medical College in Vellore.

He is specifically interested in multiple myeloma, lymphoma, pediatric and adult leukaemia, MDS, MPN, and benign hematological diseases such as anaemia, thrombocytopenia, aplastic anemia, immunodeficiency syndrome, bleeding disorders, and coagulation disorders. He also has extensive experience with blood/bone marrow stem cell transplantation [autologous and allogeneic stem cell transplantation], having successfully completed over 75 transplants during his career.

Dr. Mobin Paul’s Qualifications

MBBS
MD – General Medicine
DM – Clinical Haematology (CMC Vellore)

Dr. Mobin Paul’s Speciality

Malignant Haematology – Myeloma, Lymphoma, Paediatric and adult leukaemia, MDS, MPN
Blood /bone marrow stem cell transplantation and immunotherapy
Benign Haematological Disorders
Bleeding disorders and coagulation disorders.

Dr. Mobin Paul’s Research and Publications

Chepsy Philip, Mobin Paul, and HCC collaborators. Acute Myeloid Leukemia during the COVID Pandemic: Impact and the Indian Experience. Blood (2022) 140 (Supplement 1): 8127–8128.
Rasmi Suresh Yawalkar, Mobin Paul et al. Bortezomib Maintenance Appears Feasible, Safe and Effective in Newly Diagnosed Multiple Myeloma in a Resource Limited Setting – a Retrospective Analysis from South India. Blood (2022) 140 (Supplement 1): 8082–8084.
Sandeep Patnaik, Mobin Paul et al. Light Chain (AL) Cardiac Amyloidosis: A Real-World Data on Therapy and Outcomes. Blood (2022) 140 (Supplement 1): 12578–12580.
Chitresh Yadav, Mobin Paul et al. Fludarabine Treosulphan Conditioning Regimen Appears Safe and Effective in Patients with Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Undergoing Allogenic Hematopoietic Stem Cell Transplantation (HSCT). Blood (2022) 140 (Supplement 1): 12816–12818.
Jose A, Thomas J, Simon SP, Paul Mobin, Abraham LK, Menon RT. Thalidomide‐induced IgA vasculitis in a post‐autologous stem cell transplant recipient. Indian J Nephrol 2023; XX: XX‐XX
Hasha Thankom Somson, Mobin Paul, Jalaja Mary George, Jolsana Augustine, Rajesh Venkitakrishnan, Melcy Cleetus, Divya Ramachandran. Multiple myeloma with myelomatous pleural effusion and mediastinal plasmacytoma – a rare association. Journal of Advanced Lung Health 2023;3:113-6.
Gohul G J, Mobin Paul, Neeraj Sidharthan et al. Exploring sleep study as a potential diagnostic tool for polycythaemia: An Indian perspective. Blood( 2023) 142 (Supplement1) :5211
Rashmi Yawalkar, Mobin Paul, Neeraj Sidharthan et al. Fluorescent in situ hybridization analysis in multiple myeloma: Enhancing risk stratification, autologous transplant utilization, and treatment decisions in limited resource settings. Blood( 2023) 142 (Supplement1) :2420
Monisha H, Mobin Paul, Neeraj Sidharthan et al. Hematological manifestations of antiphospholipid antibodies: a case series from South India. Blood( 2023) 142 (Supplement1) :7307
Santhosh Kumar, Mobin Paul, Prasanna Samuel et al. Mixed phenotypic acute leukemia – clinical presentation, prognosis, and outcomes of patients with acute lymphoblastic leukemia-like protocols: a multi-institutional study from India. Blood( 2023) 142 (Supplement1) :1463
Akhil Rajendra, Mobin Paul, Uday Kulkarni et al, Outcomes and prognostic factors in patients with primary mediastinal B cell lymphoma: An experience from Haematology Cancer Consortium. Blood( 2023) 142 (Supplement1) :3141
Prasanth Ganesan, Mobin Paul, Prasanna Samuel et al. Outcomes of Philadelphia chromosome (Ph) positive acute lymphoblastic leukemia: an Indian multi-institutional, prospective study from Haematology Cancer Consortium (HCC). Blood( 2023) 142 (Supplement1) :5821
Lingaraj Nayak, Mobin Paul, Sushil Selvarajan et al. Patterns of care and outcomes in adolescent and young adults (AYA)lymphomas – a multicenter HCC (Hematology Cancer Consortium) registry study from India. Blood( 2023) 142 (Supplement1) :2412
Rajan Kapoor, Mobin Paul, Vikram Mathews et al. To study outcomes in young CML (chronic myeloid leukemia) treated with TKI. A registry dataset from the Hematological Cancer Consortium (HCC) of India. Blood( 2023) 142 (Supplement1) :4542
Chitresh Yadav, Mobin Paul, Neeraj Sidharthan. Treatment challenges in acute myeloid leukemia in lower-middle-income countries: Navigating intensity, affordability, and infections. Blood( 2023) 142 (Supplement1) :5180
Subha M Surendran, Mobin Paul, Chryselle Olive D’Souza, Latha Abraham. The clinicopathological spectrum and driver mutation profile in classic BCR-ABL1-negative myeloproliferative neoplasm: a three-year study from a tertiary care center in Kerala, South India. Int J Res Med Sci. 2024 Feb;12(2):492-497.
Jolsana Augustine, Mobin Paul, Mariyam Beevi, Rajesh Venkitakrishnan, Divya Ramachandran. A unique case of bilateral chylothorax in a patient treated with dasatinib for CML. Journal of Pulmonary Research & Reports. February 2024. Vol6(2):1-3.